NCT04604899: A trial that was reported late by jCyte, Inc
This trial has reported, although it was 119 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04604899 |
|---|---|
| Title | A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 1, 2020 |
| Completion date | March 22, 2022 |
| Required reporting date | March 22, 2023, midnight |
| Actual reporting date | July 19, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 119 |